Stocks · Health care · Biological Products, (No Diagnostic Substances)

CRISPR Therapeutics AG

CRSP Clue Score37

Switzerland Fiscal year ends December CIK 0001674416 Results filed 2 Nov 2026

Add to watchlist

What the insiders did Net selling

Individual transactions

Insider

Date

Role

Action

Price

Amount

Samarth Kulkarni

22 Jan 2026

Chief Executive Officer

Sold on a plan

60,000

$60.23

$3.61M

Samarth Kulkarni

20 Jan 2026

Chief Executive Officer

Sold on a plan

8,567

$52.10

$446.34K

Samarth Kulkarni

20 Jan 2026

Chief Executive Officer

Sold on a plan

21,433

$51.61

$1.11M

Raju Prasad

22 Dec 2025

Chief Financial Officer

Sold on a plan

1,000

$56.89

$56.89K

Raju Prasad

22 Dec 2025

Chief Financial Officer

Sold on a plan

5,472

$56.33

$308.26K

Raju Prasad

22 Dec 2025

Chief Financial Officer

Sold on a plan

3,528

$55.10

$194.40K

Show all 30 transactions →

What was left out

Form 4 filings counted 46

Amendments (4/A) skipped 0

Filings about a different issuer 0

Unreadable filings 0

Joint filings 0

Sales on a Rule 10b5-1 plan 6

Sales straight out of an exercise 8

Sales at will 16

Transactions with no price 0

Shares from compensation/vesting 415,520

History held since 20 Oct 2016